Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 52Lung Neoplasms 11Breast Neoplasms 11Head and Neck Neoplasms 8Neoplasms 5Neoplasm Metastasis 4NSCLC 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Colorectal Neoplasms 3Carcinoma 3Brain Neoplasms 3Respiratory Tract Diseases 2Neoplasms, Squamous Cell 2Carcinoma, Squamous Cell 2Adenocarcinoma of Lung 2Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC 1Small Cell Lung Carcinoma 1Respiratory Tract Neoplasms 1Pancreatic Neoplasms 1Non-Metastatic Prostate Cancer 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma 1Lung Diseases 1

Interventions

Gemcitabine 205130-nm albumin-bound paclitaxel 84Albumin-Bound Paclitaxel 57pembrolizumab 43Fluorouracil 41Leucovorin 34Oxaliplatin 33Capecitabine 25Nivolumab 22Irinotecan 19Bevacizumab 17Paclitaxel 16Cyclophosphamide 15Cetuximab 15Taxes 13Erlotinib Hydrochloride 13Drug Therapy 13Carboplatin 12irinotecan sucrosofate 11Injections 10Cisplatin 9fludarabine 8ALT-803 8spartalizumab 7olaparib 7avelumab 7Pemetrexed 7Docetaxel 7ruxolitinib 6TH 302 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Pancreatic Neoplasms × Gefitinib × Clear all
NCT00234416 2009-04-23

IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer

AstraZeneca

Phase 1/2 Completed
45 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡